Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
Marina Kohara(Jichi Medical University), Daisuke Nagata(Jichi Medical University), Takahiro Masuda(Jichi Medical University), Eiji Kusano(Edogawa Hospital), Tetsu Akimoto(Jichi Medical University), Kazuhiro Shiizaki(Koga Hospital), Makoto Kuro‐o(Jichi Medical University), Yuko Watanabe(Jichi Medical University), Chuji Sekiguchi(Sapporo Minami Hospital), Sumiko Honma(Koga Hospital), Yoshinobu Kanda(Jichi Medical University), Yasushi Asano(Koga Hospital), Yasuharu Miyazawa(Sapporo Minami Hospital)
Cited by 66
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
|Journal of Biological Chemistry|2007|731
Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice
|Journal of Biological Chemistry|2011|530
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481